Bridger Management, LLC / 2655787D
Bridger Management, LLC’s Blueprint Medicines Position
Does Bridger Management, LLC own Blueprint Medicines (2655787D)? Not currently — the last reported position was 53.3K shares worth $4M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q3 2022
Shares
53.3K
% of Portfolio
+1.07%
Quarters Held
1
position exited
Position History 2655787D
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 53.3K | $4M | +1.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of 2655787D.